These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 14534818

  • 21. Effect of diet on exocrine pancreatic insufficiency in dogs.
    Pidgeon G.
    J Am Vet Med Assoc; 1982 Aug 01; 181(3):232-5. PubMed ID: 6921199
    [Abstract] [Full Text] [Related]

  • 22. New methods for assessment of enzyme activity: do they help to optimize enzyme treatment?
    Adler G, Mundlos S, Kühnelt P, Dreyer E.
    Digestion; 1993 Aug 01; 54 Suppl 2():3-9. PubMed ID: 7693531
    [Abstract] [Full Text] [Related]

  • 23. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Piehl S, Brinkmann R, Windeck T.
    Eur J Gastroenterol Hepatol; 2010 May 01; 22(5):635-6; author reply 636-7. PubMed ID: 20393298
    [No Abstract] [Full Text] [Related]

  • 24. The effect of enzyme substitution in patients with pancreatic insufficiency.
    Worning H.
    Scand J Gastroenterol; 1980 May 01; 15(5):529-33. PubMed ID: 6160608
    [Abstract] [Full Text] [Related]

  • 25. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis.
    Lankisch PG.
    Digestion; 1993 May 01; 54 Suppl 2():21-9. PubMed ID: 8224569
    [Abstract] [Full Text] [Related]

  • 26. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M, Meuris S, Gohimont AC, Buedts K, Cremer M.
    Eur J Gastroenterol Hepatol; 1996 Jul 01; 8(7):699-703. PubMed ID: 8853261
    [Abstract] [Full Text] [Related]

  • 27. An enteric-coated pancreatic enzyme preparation that works.
    Graham DY.
    Dig Dis Sci; 1979 Dec 01; 24(12):906-9. PubMed ID: 510089
    [Abstract] [Full Text] [Related]

  • 28. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations.
    Kraisinger M, Hochhaus G, Stecenko A, Bowser E, Hendeles L.
    J Clin Pharmacol; 1994 Feb 01; 34(2):158-66. PubMed ID: 8163716
    [Abstract] [Full Text] [Related]

  • 29. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.
    Trang T, Chan J, Graham DY.
    World J Gastroenterol; 2014 Sep 07; 20(33):11467-85. PubMed ID: 25206255
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension.
    Seiler CM, Izbicki J, Varga-Szabó L, Czakó L, Fiók J, Sperti C, Lerch MM, Pezzilli R, Vasileva G, Pap A, Varga M, Friess H.
    Aliment Pharmacol Ther; 2013 Apr 07; 37(7):691-702. PubMed ID: 23383603
    [Abstract] [Full Text] [Related]

  • 33. Exocrine pancreatic substitution: facts and controversies.
    Worning H.
    Scand J Gastroenterol Suppl; 1986 Apr 07; 126():49-54. PubMed ID: 3470919
    [Abstract] [Full Text] [Related]

  • 34. What to do when a patient with exocrine pancreatic insufficiency does not respond to pancreatic enzyme substitution, a practical guide.
    Lankisch PG.
    Digestion; 1999 Apr 07; 60 Suppl 1():97-103. PubMed ID: 10026441
    [Abstract] [Full Text] [Related]

  • 35. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
    Pap A, Varró V.
    Hepatogastroenterology; 1984 Feb 07; 31(1):47-50. PubMed ID: 6199274
    [Abstract] [Full Text] [Related]

  • 36. [Pancreatic extract therapy in exocrine pancreatic insufficiency].
    Santini B, Ivaldi AP.
    Minerva Gastroenterol Dietol; 1993 Sep 07; 39(3):133-7. PubMed ID: 8286485
    [Abstract] [Full Text] [Related]

  • 37. Response to: properties of different pancreatin preparations used in pancreatic exocrine insufficiency, Löhr JM et al. Eur J Gastroenterol Hepatol 2009; 21(9):1024-1031.
    Lederer PC.
    Eur J Gastroenterol Hepatol; 2010 May 07; 22(5):635; author reply 636-7. PubMed ID: 20393299
    [No Abstract] [Full Text] [Related]

  • 38. Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency.
    Aloulou A, Schué M, Puccinelli D, Milano S, Delchambre C, Leblond Y, Laugier R, Carrière F.
    Gastroenterology; 2015 Dec 07; 149(7):1910-1919.e5. PubMed ID: 26327131
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Fat absorption and gastroenteric pH profile in postsurgical pancreatic insufficiency: role of the association of H2-receptor antagonists with pancreatic enzymes.
    Braga M, Zerbi A, Malesci A, Dal Cin S, Valentini A, Tacconi M, Erenbourg L, Paganelli M, Di Carlo V.
    Pancreas; 1993 Jul 07; 8(4):494-8. PubMed ID: 8103218
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.